QUICK LINKS  CORPORATE LINKS  SEARCH


 

Clinical Studies

 

National Starch has been collaborating with researchers around the world to investigate the health benefits of Hi-maize and Novelose resistant starches for many years.  The studies represented on this site are a selection of the research that exists today. As new research becomes available, we will make every effort to communicate in this space. Please check back regularly.

Select studies on Hi-maize and resistant starches

 

There is substantial research on the health benefits of natural Hi-maize, including about 300 peer-reviewed nutritional studies carried out over the last 20 years.  These studies illustrate that these benefits range from weight management, glycemic (blood sugar) management,  and digestive health.  More than 80 studies in humans using natural Hi-maize provides a high level of confidence that the benefits are reliable and real.  

 

Studies have confirmed that different types of resistant starches deliver different benefits. Thus, benefits demonstrated by Hi-maize cannot be extrapolated to other types of resistant starches.

 

 

Today, surveys show clearly that consumers seek the specific health benefits that Hi-maize can provide (see Consumer Research section of this website). People are becoming increasingly aware of the importance of dietary fiber – and the differences between dietary fibers.  The particular benefits of Hi-maize can be utilized to appeal to segments of consumers beyond those looking for dietary fiber. 

 

The volume and findings of research on natural resistant starch are compelling.  Below are just a few select studies:

  

Digestive Health

 

Hi-maize resistant starch promotes digestive health.

 

·         Hi-maize selectively increases beneficial bacteria, while suppressing harmful bacteria – what’s called a ‘prebiotic’ fiber. (Brown 1997) 

·         The fermentation of Hi-maize increases SCFA production (butyrate is particularly important for colon health), which reduces intestinal pH and reduces the production of potentially harmful ammonia and phenols. (Birkett 1996)

·         Hi-maize promotes regularity with a mild laxative effect. (Phillips 1995)

·         Hi-maize assists in restoring normal intestinal function in individuals with diarrhea. (Ramakrishna 2000, Ramakrishna 2008)

 

 [ Brown I, Warhurst M, Arcot J, Playne M, Illman RJ, Topping DL.  Fecal numbers of bifidobacteria are higher in pigs fed Bifidobacterium longum with a high amylose cornstarch than with a low amylose cornstarch. The Journal of Nutrition (1997) 127:1822-1827.

 

Birkett, A., Muir, J.G., Phillips, J., Jones, G., O’Dea, K. Resistant starch lowers fecal concentrations of ammonia and phenols in humans. American Journal of Clinical Nutrition (1996), 63, 766-772.

 

Phillips, J., Muir, J.G., Birkett, A., Lu, Z.X., Jones, G.P., O’Dea, K. Effect of resistant starch on fecal bulk and fermentation-dependent events in humans. American Journal of Clinical Nutrition (1995) 62, 121-130.

 

Ramakrishna BS, Venkataraman, S, Srinivasan P, Dash P, Young, GP, Binder HJ.  Amylase-resistant starch plus oral rehydration solution for cholera.  New England Journal of Medicine (2000) 342:308-13.

 

Ramakrishna, B.S., Subramanian V., Mohan V., Sebastian B.K., Young G.P., Farthing M.J., Binder H.J.  A randomized controlled trial of glucose versus amylase resistant starch hypo-osmolar oral rehydration solution for adult acute dehydrating diarrhea. PLoS ONE (February 13, 2008) 3(2): e1587]

 

 

Glycemic Management: Healthy Blood Sugar Levels

 

Hi-maize resistant starchreduces the impact on blood sugar (glycemic) and blood insulin levels when replacing rapidly digestible carbohydrates such as flour.

 

Multiple studies have confirmed that when Hi-maize replaces flour or other rapidly digestible carbohydrates such as cornstarch, the glycemic (blood sugar) and blood insulin impact of that food is reduced.  Studies have been published by investigators around the world – i.e. Dr. M. Olesen at the University of Copenhagen and Dr. Manny Noakes at the CSIRO in Australia. Delayed or sustained energy release has also been demonstrated in some studies with consumption of resistant starch from high amylose corn.  Studies published by Dr. Kay Behall and her colleagues at the US Department of Agriculture have shown that the reductions in glycemic and insulin response are relative to the amount of RS incorporated into the food and increase with increasing amylose content of the corn starch. 

 

Dr. Denise Robertson and her colleagues  at the University of Surrey in the UK showed that consumption of Hi-maize increased insulin sensitivity in healthy people by 33%.  A 2005 study confirmed that increased insulin sensitivity was increased after 4 weeks of Hi-maize resistant starch consumption. 2009 and 2010 studies demonstrated improvements in insulin sensitivity in individuals with insulin resistance and Metabolic Syndrome.  (Robertson, 2009 and Johnson 2010) This is important because insulin resistance is an underlying risk factor in metabolic syndrome, with increased risk for developing diabetes, obesity, and cardiovascular disease.

 

[Olesen M, Rumessen JJ, Gudmand-Hoyer E. Intestinal transport and fermentation of resistant starch evaluated by the hydrogen breath test.  European Journal of Clinical Nutrition 1994;48(10):692-701.

 

Noakes M, Clifton PM, Nestel PJ, Le Leu R, McIntosh G. Effect of high-amylose starch and oat bran on metabolic variables and bowel function in subjects with hypertriglyceridemia. The American Journal of Clinical Nutrition 1996;64(6):944-51.

 

Behall KM, Scholfield DJ, Canary J. Effect of starch structure on glucose and insulin responses in adults.

The American Journal of Clinical Nutrition 1988;47(3):428-32.

 

Behall KM, Hallfrisch J. Plasma glucose and insulin reduction after consumption of breads varying in amylose content. European Journal of Clinical Nutrition 2002;56(9):913-20.

 

Robertson MD, Bickerton AS, Dennis AL, Vidal H and Frayn KN: Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism.   The American Journal of Clinical Nutrition 2005;82:559–67.

 

Robertson MD, Wright JW, Batt J, Russell-Jones D, Umpleby AM.  Dietary resistant starch is an insulin sensitizer.  A37(P37). Diabetic Medicine.  2009:26(Supp. 1):14.

Johnson KL, Thomas EL, Bell JD, Frost GS, Robertson MD.  Resistant starch improves insulin sensitivity in metabolic syndrome.  Diabetic Medicine (April 2010):27(4):391-397. 

 

 

Weight Management

 

 

Resistant starch lowers calories when it replaces flour or other digestible carbohydrates.

 

Dr. Kay Behall and her colleagues at the US Department of Agriculture confirmed that high amylose corn RS2 does not yield the full 4 kilocalories per gram typical of flour, but delivers between 2 - 3 kcal/gram.  Thus, when Hi-maize is used to replace flour, the caloric content of that food is reduced.  The energy is partially delivered in the small intestine through the digestion of the starch portion and part of the energy is delivered in the large intestine in the form of short-chain fatty acid by-products from the fermentation of the resistant starch.

 

A study published by Dr. Janine Higgins at University of Colorado suggests that eating just one meal containing high amylose corn RS2 resistant starch can increase lipid oxidation (fat-burning) in healthy people by 20-25%. 

 

An area of emerging importance for weight management is satiety. Numerous studies have shown that Hi-maize resistant starch increase satiety and help people eat less, both over the short-term (2-3 hours) as well as over 24 hours.  These studies were published by Dr. Joanne Slavin and her colleagues at the University of Minnesota, Dr. Harvey Anderson and his colleagues at the University of Toronto, Dr. Denise Robertson and her colleagues at Surrey University and Dr. Nilsson and her colleagues at Lund University.  Studies published 10 or more years ago did not always demonstrated increased satiety, however.

 

Animal studies have already been published which support the use of Hi-maize in foods for weight management.  Dr. Dorota Pawlak at Harvard Medical School in Boston MA, Dr. Michael Keenan at Louisiana State University and Dr. M.O. Weickert at the University of Warwick in the United Kingdom have both demonstrated that animals fed Hi-maize resistant starch had significantly less body fat compared to animals fed a high glycemic, rapidly digested cornstarch diet (up to 50% less body fat in some studies). In addition, Dr. Keenan and his colleagues have shown that the fermentation of Hi-maize resistant starch increases the production of satiety hormones within the large intestine.

 

  

[Behall, KM, Howe JC.  Resistant starch as energy.  The Journal of the American College of Nutrition 1996;15(3):248-54.

 

Higgins JA, Higbee DR, Donahoo WT, Brown IL, Bell ML, Bessesen DH, 2004. Resistant starch consumption promotes lipid oxidation. Nutrition & Metabolism 1:8.

Willis HJ, Eldridge AL, Beiseigel J, Thomas W, Slavin JL. Greater satiety response with resistant starch and corn bran in human subjects.  Nutrition Research.  (February 2009) 29(2):100-105.

Nilsson A.C., Ostman E.M., Holst J.J., Bjorck I.M.E. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast.  Journal of Nutrition (2008) 138:732-739.

Anderson GH, Cho CE, Akhavan T, Mollard RC, Lohovyy BL, Finocchiaro ET.  Relation between estimates of cornstarch digestibility by the Englyst in vitro method and glycemic response, subjective appetite, and short-term food intake in young men.  American Journal of Clinical Nutrition.  (April 2010) 91(4):932-9.

Bodinham CL, Frost GS, Robertson MD.  Acute ingestion of resistant starch reduces food intake in healthy adults.  British Journal of Nutrition. (March 2010), 103(6):917-922.Pawlak DB, Kushere JA, Ludwig DS. Effects of dietary glycaemic index on adiposity, glucose homeostasis, and plasma lipids in animals. The Lancet 2004;364:778-85.

 

Keenan, M.J., Zhou, J., McCutcheon, K.L., Raggio, A.M., Bateman, H.G., Todd, E., Jones, C.K., Tulley, R.T., Melton, S., Martin, R.J., Hegsted, M. Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity, (2006), 14 (9), 1523-1534.

 

Isken F, Klaus S, Petzke KJ, Loddenkemper C, Pfeiffer AFH, Weickert MO.  Impairment of fat oxidation under high- vs. low-glycemic index diet occurs before the development of an obese phenotype.  American Journal of Physiology: Endocrinology and Metabolism (2010)  298: 287-295

 

Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, Shen L, Danna SC, Tripathy S, Hegsted M, Keenan MJ.   Dietary resistant starch up-regulates total GLP-1 and PYY in a sustained daylong manner through fermentation in rodents  American Journal of Physiology: Endocrinology and Metabolism (2008) 295: 1160-1166.]

 

Overview of human studies with resistant starch

 

 

 

Overview of human studies with Natural RS2 Resistant Starch

 

The benefits of natural RS2 resistant starch from high amylose corn are attributed to both the reduced glycemic and insulin response within the small intestine, as well as to the fermentation effects within the large intestine. While all dietary fibers decrease the glycemic and insulin response when they substitute for digestible carbohydrates, the fermentation effects distinguish resistant starch from other types of dietary fiber. The fermentation of natural resistant starch promotes a healthy colon but has also been shown to significantly improve metabolism (i.e., increases insulin sensitivity and increases lipid oxidation). In other words, its health benefits range far beyond the colon – its helps to maintain overall health and wellness through multiple mechanisms.

Summary of published human clinical studies with natural RS2 resistant starch from high amylose corn (RS2):

§ 9 studies have shown beneficial effects on outcomes relevant to weight management and metabolism. One study confirmed the caloric contribution of RS2 resistant starch (2.8 kilocalories/gram). (Behall, JACN 1996).   Four out of five  studies have shown increased insulin sensitivity in healthy individuals and Type II diabetics (Robertson D 2003, Robertson AJCN 2005, Zhang CJPM 2007, Johnston DM 2010, Penn-Marshall JMF 2010). Another study showed increased fat burning (lipid oxidation) in healthy individuals (Higgins, NM 2004), while three studies have demonstrated increased satiety (van Amelsvoort, AJCN 1992, Nilsson, JN 2008 and Willis NR 2009).  One study found that healthy individuals consumed 10% fewer calories in the 24 hours following Hi-maize consumption. (Bodinham, PNAS 2008)  Finally, another study found that healthy young men consumed fewer calories  two hours following consumption of Hi-maize resistant starch (Anderson, AJCN 2010) 

§ 23 studies have shown beneficial effects of RS2 from high amylose corn on glucose and/or insulin response. When substituted for flour, it lowers the glycemic and/or insulin response of foods in a dose-dependent manner. (Anderson, AJCN 2002; Behall, AJCN 1988 - reduced peak; Behall, AJCN, 1989 - significant reduction within first hour; Behall & Howe, AJCN 1995; Behall & Hallfrisch, EJCN, 2002; Behall & Scholfield, CC, 2005; Behall, DC 2006; Behall, NR 2006; Brighenti, AJCN 2006; Brown, FA 1995; Giacco, DNM 1998; Granfeldt, JN 1995; Hoebler, EJCN 1999; Hospers, JFS 1996 - significant reduction within first hour; Howe, JN 1996; Krezowski, DC 1987; Noakes, AJCN 1996; Olesen, EJCN 1994; Reader, JADA 2002; van Amelsvoort & Weststrate, AJCN 1992; Vonk, AJCN 2000; Weststrate & van Amelsvoort, AJCN 1993; Zhang, CJPM 2007)

§ 5 studies have shown decreased glycemic or insulin response of the subsequent meal. (Behall, AJCN 1989; Robertson, D 2003; Robertson, AJCN 2005; Brighenti, AJCN 2006, Nilsson, JN 2008)

§ 4 studies have shown increased insulin sensitivity in healthy people, in individuals with insulin resistance and metabolic syndrome and in individuals with diabetes. (Robertson D 2003; Robertson AJCN 2005; Zhang CJPM 2007; Johnston 2010).  One additional study found no significant effect on insulin sensitivity after feeding subjects at risk for type 2 diabetes 12 grams of Hi-maize 260/day for 6 weeks (Penn-Marshall JMF 2010). The authors found significant improvements in glucose homeostasis in one male subject diagnosed with prediabetes and suggested that the quantity of resistant starch may not have been sufficient for the other subjects.

§ 13 out of 14 studies have demonstrated beneficial effects on biomarkers for colon health such as the production of short-chain fatty acids, lower pH, lower concentrations of ammonia and phenolics, decreased bile acids, and increased fecal weight. (Alles, AJCN 1997; Birkett, AJCN 1996; Grubben, DDS, 2001; Heijnen, AJCN 1996; Heijnen, AJCN 1998; Hylla, AJCN 1998; Jenkins, JACN 1998; Muir, AJCN 2004; Noakes, AJCN 1996; Phillips, AJCN 1995; Silvester, NC 1997; van Munster, DDS 1994; Wacker, CEBP 2002, Worthley, AJCN 2009). The authors of the study which did not demonstrate beneficial effect suggested that they did not achieve sufficient quantity of resistant starch in the diet, (Worthley, AJCN, 2009)

§ 2 studies have been published out of the CAPP2 study (Colorectal Adenoma/Carcinoma Prevention Program 2, in which 727 individuals participated in 43 centers around the world over an average of 29 months). They found that 30 grams of resistant starch - a combination of Novelose 330 (RS3) and Hi-maize 240 (RS2) resistant starch- did not reduce the risk for colorectal cancer in individuals with Lynch syndrome (hereditary non-polyposis colon cancer). Up to 5% of colorectal cancers result from the Lynch syndrome. (Burn, NEJM 2008) A second study examined a sub-segment of 65 patients with colorectal cancer and found reduction in markers for colon cancer in normal tissue as well as increased genetic expression of cell cycle regulatory genes. (Dronamraju, G 2008)


§ 4 out of 5 published studies have shown reduced duration and severity of diarrhea in adults and children when Hi-maize was added to oral rehydration solutions. The one study not demonstrating effectiveness (Alam 2009) suggested that the children may have had insufficient bacteria in their large intestines due to antibiotic treatments. (Alam JPGN 2009, Monira JPGN 2009, Ramakrishna, PLoS ONE 2008, Rangupathy, JPGN 2006; Ramakrishna, NEJM 2000)

 

References for the Clinical Studies Cited Above:

Alam NH, Islam S, Sattar S, Monira S, Desjeux JF. Safety of rapid intravenous rehydration and comparative efficacy of 3 oral rehydration solutions in the treatment of severely malnourished children with dehydrating cholera. Journal of Pediatric Gastroenterology & Nutrition. 2009 Mar;48(3):318-27.

Alles MS, Katan MB, Salemans JMJI, Van Laere KMJ, Gerichhausen MJW, Rozendaal MJ, Nagengast FM. Bacterial fermentation of fructooligosaccharides and resistant starch in patients with an ileal pouch – anal anastomosis. The American Journal of Clinical Nutrition 1997;66:1286-92.

Anderson GH, Cho CE, Akhavan T, Mollard RC, Luhovyy BL, Finocchiaro ET. Relation between estimates of cornstarch digestibility by the Englyst in vitro method and glycemic response, subjective appetite, and short-term food intake in young men. American Journal of Clinical Nutrition (February 17, 2010) Epub ahead of print. doi:10.3945/ajcn.2009.28443.

Anderson GH, Catherine NLA, Woodend DM, Wolever TMS. Inverse association between the effect of carbohydrates on blood glucose and subsequent short-term food intake in young men. The American Journal of Clinical Nutrition 2002;76:1023-30.

Behall KM, Scholfield DJ, and Canary J. Effect of starch structure on glucose and insulin responses in adults. The American Journal of Clinical Nutrition 1988; 47(3): 428-32.

Behall KM, Scholfield DJ, Yuhaniak I, Canary J. Diets containing high amylose vs. amylopectin starch: effects on metabolic variables in human subjects. The American Journal of Clinical Nutrition 1989;49(2): 337-44.

Behall KM, and Howe JC. Effect of long-term consumption of amylose vs amylopectin starch on metabolic variables in human subjects. The American Journal of Clinical Nutrition 1995;61(3): 334-340.

Behall KM, Howe JC. Resistant starch as energy. Journal of the American College of Nutrition 1996;15(3): 248-54.

Behall KM, and Hallfrisch J. Plasma glucose and insulin reduction after consumption of breads varying in amylose content. European Journal of Clinical Nutrition 2002;56(9): 913-20.

Behall KM, Howe JC, and Anderson RA. Apparent mineral retention is similar in control and hyperinsulinemic men after consumption of high amylose cornstarch. Journal of Nutrition 2002;132:1886-91.

Behall KM, Scholfield DJ. Food amylose content affects postprandial glucose and insulin responses. Cereal Chemistry. 2005;82(6):654-659.

Behall KM, Hallfrisch JG, Scholfield DJ, Liljeberg-Elmstahl HGM. Consumption of both resistant starch and beta-glucan improves postprandial plasma glucose and insulin in women. Diabetes Care. 2006;29(5):976-981.

Behall, K.M., Scholfield, D.J., Hallfrisch, J.G., Barley beta-glucan reduces plasma glucose and insulin responses compared with resistant starch in men Nutrition Research December, 2006;26(12):644-650.

Birkett A, Muir J, Phillips J, Jones G, O'Dea K. Resistant starch lowers fecal concentrations of ammonia and phenols in humans. The American Journal of Clinical Nutrition 1996;63(5):766-72.

Bodinham CL, Frost GS, Robertson MD.  Acute ingestion of resistant starch reduces food intake in healthy adults. British Journal of Nutrition (Mar 2010) 103(6):917-22.

Brighenti F, Benini L, Del Rio D, Casiraghi D, Pellegrini N, Spazzina F, Jenkins DJA., Vantini I. Colonic fermentation of indigestible carbohydrates contributes to the second-meal effect. The American Journal of Clinical Nutrition 2006; 83:817-822.

Brown IL, McNaught KJ, Moloney E. Hi-maize™: new directions in starch technology and Nutrition.  Food Australia, June 1995;47(6):272-5.

Burn J. Bishop T, Mecklin JP, Macrae F, Moslein G, Olschwang S, Bisgaard ML, Ramesar R, Eccles D, Maher ER, Bertario L, Jarvinen HJ, Lindblom A, Evans G, Lubinski J, Morrison P, Ho JWC, Vasen HFA, Side L, Thomas HJW, Scott RJ, Dunlop M, Barker G, Elliott F, Jas JR, Fodde R, Lynch HT, Mathers JC. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch Syndrome New England Journal of Medicine, 2008;359;24:2567-78.

Dronamraju SS, Coxhead JM, Kelly SB, Burn J, Mathers JC. Cell kinetics and gene expression changes in colorectal cancer patients given resistant starch – A randomized controlled trial. Gut  (2009) Mar;58(3):413-20.

Giacco R, Clemente G, Brighenti F, Mancini M, D’Avanzo A, Coppola S, Ruffa G, La sorella G, Rivieccio AM, Rivellese AA, Riccardi G. Metabolic effects of resistant starch in patients with Type 2 diabetes. Diabetes, Nutrition & Metabolism 1998;11:330-5.

Granfeldt Y, Drews A, and Bjorck I. Arepas made from high amylose corn flour produce favorably low glucose and insulin responses in healthy humans. Journal of Nutrition 1995;125(3): 459-65.

Grubben MJ, van den Braak CC, Essenberg M, Olthof M, Tangerman A, Katan MB, Nagengast FM. Effect of resistant starch on potential biomarkers for colonic cancer risk in patients with colonic adenomas: a controlled trial. Digestive Diseases and Science 2001;46(4):750-6.

Heijnen M-LA, van Amelsvoort JMM, Deurenberg P, Beynen AC. Neither raw nor retrograded resistant starch lowers fasting serum cholesterol concentrations in healthy normolipidemic subjects. The American Journal of Clinical Nutrition 1996;64:312-8.

Heijnen M-LA, van Amelsvoort JMM, Deurenberg P, Beynen AC. Limited effect of consumption of uncooked (RS2) or retrograded (RS3) resistant starch on putative risk factors for colon cancer in healthy men. The American Journal of Clinical Nutrition 1998;67:322-31.

Higgins JA, Higbee DR, Donahoo WT, Brown IL, Bell ML, Bessesen DH. Resistant starch consumption promotes lipid oxidation. Nutrition & Metabolism 2004;1:8.

Hoebler C, Karinthi A, Chiron H, Champ M, Barry J-L. Bioavailability of starch in bread rich in amylose: metabolic responses in healthy subjects and starch structure. European Journal of Clinical Nutrition 1999;53(5): 360-6.

Hospers JJ, van Amelsvoort JMM, and Weststrate JA. Amylose-to-amylopectin ratio in pastas affects postprandial glucosee and insulin responses and satiety in males. Journal of Food Science 1994;59(5): 1144-9.

Howe JC, Rumpler WV, and Behall KM. Dietary starch composition and level of energy intake alter nutrient oxidation in "carbohydrate-sensitive" men. Journal of Nutrition 1996;126(9): 2120-9.

Hylla S, Gostner A, Dusel G, Anger H, Bartram HP, Christl SU, Kasper H, Scheppach W. Effects of resistant starch on the colon in healthy volunteers: possible implications for cancer prevention. The American Journal of Clinical Nutrition 1998;67(1):136-42.

Jenkins DJA, Vuksan V, Kendall CWC, Wursch P, Jeffcoat R, Waring S, Mehling CC, Vigden E, Augustin LSA, Wong E. Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index. Journal of the American College of Nutrition 1998;17(6):609-16.

Johnson KL, Thomas EL, Bell JD, Frost GS, Robertson MD. Resistant starch improves insulin sensitivity in metabolic syndrome. Diabetic Medicine (2010):27(4):391-397.

Krezowski PA, Nuttall FQ, Gannon MC, Billington CJ, Parker S. Insulin and glucose responses to various starch-containing foods in Type II diabetic subjects. Diabetes Care 1987;10(2): 205-12.

Magee EA, Edmond LM, Tasker SM, Kong SC, Curno R, Cummings JH. Associations between diet and disease activity in ulcerative colitis patients using a novel method of data analysis. Nutrition Journal 2005;4:7.

Monira S, Alam NH, Suau A, Magne F, Nair GB, Karmakar PC, Rahman M, Pochart P, Desieux JF. Time course of bacterial diversity in stool samples of malnourished children with cholera receiving treatment. Journal of Pediatric Gastroenterology & Nutrition 2009 Feb 25 (Epub ahead of print)

Muir JG, Yeow EG, Keogh J, Pizzey C, Bird AR, Sharpe K, O'Dea K, Macrae FA. Combining wheat bran with resistant starch has more beneficial effects on fecal indexes than does wheat bran alone. The American Journal of Clinical Nutrition 2004;79(6):1020-8.

Nilsson AC, Östman EM, Holst JJ, Björck IME. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. The Journal of Nutrition 2008;138:732-9. 

Noakes M, Clifton PM, Nestel P, Le Leu R, McIntosh G. Effect of high-amylose starch and oat bran on metabolic variables and bowel function in subjects with hypertriglyceridemia. The American Journal of Clinical Nutrition 1996;64(6):944-51.

Olesen M, Rumessen JJ, Gudmand-Hoyer E. Intestinal transport and fermentation of resistant starch evaluated by the hydrogen breath test. European Journal of Clinical Nutrition 1994;48(10):692-701.

Penn-Marshall M,Holtzman GI, Barbeau WE. African Americans may have to consumer more than 12 grams a day of resistant starch to lower their risk for Type 2 diabetes. Journal of Medicinal Food (2010) 13(4):1-6. [Epub ahead of print May 18, 2010.]

Phillips J, Muir JG, Birkett A, Lu ZX, Jones GP, O’Dea K. Effect of resistant starch on fecal bulk and fermentation-dependent events in humans. The American Journal of Clinical Nutrition 1995;62:121-30.

Quílez J, Bulló M, Salvadó-Salas J. Improved postprandial response and feeling of satiety after consumption of low-calorie muffins with maltitol and high-amylose corn starch. Journal of Food Science 2007;72(6):S407-S411.

Ramakrishna BS, Venkataraman S, Srinivasan P, Dash P, Young GP, Binder HJ. Amylase-resistant starch plus oral rehydration solution for cholera. The New England Journal of Medicine 2000;342(5):308-313.

Raghupathy P, Ramakrishna BS, Oommen SP, Ahmed MS, Priyaa G, Dziura J, Young GP, Binder HJ. Amylase-resistant starch as adjunct to oral rehydradation therapy in children with diarrhea. Journal of Pediatric Gastroenterology and Nutrition 2006;42(4):362-368.

Ramakrishna, BS, Subramanian V, Mohan V, Sebastian BK, Young GP, Farthing MJ, Binder HJ. (2008) A randomimzed controlled trial of glucose versus amylase resistant starch hypo-osmolar oral rehydration solution for adult acute dehydrating diarrhea. PLoS ONE 3(2): e1587. Published February 13, 2008.

Reader DM, O’Connell BS, Johnson ML, Franz M. Glycemic and insulinemic response of subjects with type 2 diabetes after consumption of three energy bars. Journal of the American Dietetic Association 2002;102: 1139-42.

Robertson MD, Currie JM, Morgan LM, Jewell DP, Frayn KN. Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia 2003;46(5):659-65.

Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. The American Journal of Clinical Nutrition 2005;82:559-567.

Robertson MD, Wright JW, Batt J. Russell-Jones D, and Umpleby AM.  Dietary resistant starch in an insulin sensitizer A37(P37). Diebetic Medicine March 2009;26(1)(Suppl. 1):14. 

Silvester KR, Bingham SA, Pollock JRA, Cummings JH, O’Neill IK. Effect of meat and resistant starch on fecal excretion of apparent N-nitroso compounds and ammonia from the human large bowel. Nutrition and Cancer 1997;29(1):13-23.

Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. The American Journal of Clinical Nutrition 2005;82:559-567.

Van Amelsvoort JMM, Weststrate JA. Amylose-amylopectin ratio in a meal affects postprandial variables in male volunteers. The American Journal of Clinical Nutrition 1992;55:712-8.

Van Munster IP, Tangerman A, Nagengast FM. Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation. Digestive Diseases and Sciences 1994:39(4):834-842.

Vonk RJ, Hagedoorn RE, de Graaff R, Elzinga H, Tabak S, Yang YX, Stellaard F. Digestion of so-called resistant starch sources in the human small intestine. The American Journal of Clinical Nutrition 2000;72(2):432-8.

Wacker M, Wanek P, Eder E, Hylla S, Gostner A, Scheppach W. Effect of enzyme-resistant starch on formation of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal and cell proliferation in the colonic mucosa of healthy volunteers. Cancer Epidemiology, Biomarkers and Prevention 2002;11:915-20.

Weststrate JA, and van Amelsvoort JMM. Effects of the amylose content of breakfast and lunch on postprandial variables in male volunteers. The American Journal of Clinical Nutrition 1993;58: 180-6.

Willis HJ, Eldridge AL, Beiseigel J, Thomas W, Slavin JL. Greater satiety response with resistant starch and corn bran in human subjects. Nutrition Research. February 2009; 29(2):100-105. 

Worthley DL, Le Leu RK, Whitehall VL, Conlon M, Christophersen C, Belobrajdic D, Mallitt K-A, Hu Y, irahara N, Ogino S, Leggett BA, Young GP.  A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and symbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer.  The American Journal of Clinical Nutrition (Sep 2009) 90:578 - 586. 

Zhang W, Wang H, Zhang Y, Yang Y. Effects of resistant starch on insulin resistance of type 2 mellitus patients. Chinese Journal of Preventive Medicine March 2007;41(2):101-104.

 

 

 

Hi-maize is available for purchase in "home-use" quantities at www.kingarthurflour.com

The National Starch Food Innovation Logo is a trademark of National Starch Food Innovation

EU Disclosure Agreement | View Disclaimer | View Privacy Policy | All rights reserved. All contents Copyright ©2010